450 related articles for article (PubMed ID: 29488584)
1. [Epidemiology, species, antifungal resistance and outcome of candidemia in a university hospital in Buenos Aires, Argentina for 16 years].
Tiraboschi IN; Pozzi NC; Farías L; García S; Fernández NB
Rev Chilena Infectol; 2017 Oct; 34(5):431-440. PubMed ID: 29488584
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiology and antifungal susceptibility of species producing candidemia in Valdivia, Chile].
Márquez F; Iturrieta I; Calvo M; Urrutia M; Godoy-Martínez P
Rev Chilena Infectol; 2017 Oct; 34(5):441-446. PubMed ID: 29488585
[TBL] [Abstract][Full Text] [Related]
4. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018).
Arastehfar A; Yazdanpanah S; Bakhtiari M; Fang W; Pan W; Mahmoudi S; Pakshir K; Daneshnia F; Boekhout T; Ilkit M; Perlin DS; Zomorodian K; Zand F
Med Mycol; 2021 May; 59(5):422-430. PubMed ID: 32692816
[TBL] [Abstract][Full Text] [Related]
7. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and cost implications of candidemia, a 6-year analysis from a developing country.
Ulu Kilic A; Alp E; Cevahir F; Ture Z; Yozgat N
Mycoses; 2017 Mar; 60(3):198-203. PubMed ID: 27862414
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.
Arendrup MC; Dzajic E; Jensen RH; Johansen HK; Kjaeldgaard P; Knudsen JD; Kristensen L; Leitz C; Lemming LE; Nielsen L; Olesen B; Rosenvinge FS; Røder BL; Schønheyder HC
Clin Microbiol Infect; 2013 Aug; 19(8):E343-53. PubMed ID: 23607326
[TBL] [Abstract][Full Text] [Related]
11. Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China.
Ma CF; Li FQ; Shi LN; Hu YA; Wang Y; Huang M; Kong QQ
BMC Infect Dis; 2013 Jul; 13():337. PubMed ID: 23875950
[TBL] [Abstract][Full Text] [Related]
12. Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.
Martí-Carrizosa M; Sánchez-Reus F; March F; Coll P
Scand J Infect Dis; 2014 Jun; 46(6):454-61. PubMed ID: 24762093
[TBL] [Abstract][Full Text] [Related]
13. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.
Wisplinghoff H; Ebbers J; Geurtz L; Stefanik D; Major Y; Edmond MB; Wenzel RP; Seifert H
Int J Antimicrob Agents; 2014 Jan; 43(1):78-81. PubMed ID: 24182454
[TBL] [Abstract][Full Text] [Related]
14. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
16. Distribution and drug susceptibilities of Candida species causing candidemia from a medical center in central Taiwan.
Chang TP; Ho MW; Yang YL; Lo PC; Lin PS; Wang AH; Lo HJ
J Infect Chemother; 2013 Dec; 19(6):1065-71. PubMed ID: 23732308
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of Candidemia in Children over 7 Years in a Medical Center in Turkey.
Yılmaz-Ciftdoğan D; Kara-Aksay A; Erbaş G; Sarkış ÜB; Karadağ-Oncel E; Anıl AB; Baran M; Er H; Yılmaz N
Microbiol Spectr; 2021 Oct; 9(2):e0045321. PubMed ID: 34550003
[TBL] [Abstract][Full Text] [Related]
18. Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients.
Lortholary O; Desnos-Ollivier M; Sitbon K; Fontanet A; Bretagne S; Dromer F;
Antimicrob Agents Chemother; 2011 Feb; 55(2):532-8. PubMed ID: 21078946
[TBL] [Abstract][Full Text] [Related]
19. Candidemia in major burns patients.
Renau Escrig AI; Salavert M; Vivó C; Cantón E; Pérez Del Caz MD; Pemán J
Mycoses; 2016 Jun; 59(6):391-8. PubMed ID: 26931414
[TBL] [Abstract][Full Text] [Related]
20. Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals.
Colombo AL; Garnica M; Aranha Camargo LF; Da Cunha CA; Bandeira AC; Borghi D; Campos T; Senna AL; Valias Didier ME; Dias VC; Nucci M
Med Mycol; 2013 Jan; 51(1):38-44. PubMed ID: 22762208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]